CALGB

Related by string. * * Group B CALGB . CALGB # [001] . CALGB # [002] *

Related by context. Frequent words. (Click for all words.) 73 SWOG 73 RTOG 72 NSABP 72 EORTC 71 Gynecologic Oncology Group 70 randomized Phase III 70 Radiation Therapy Oncology 67 Phase Ib clinical 66 National Surgical Adjuvant 66 SABCS 66 placebo controlled clinical 65 neoadjuvant 65 pertuzumab 65 Phase III randomized 64 Phase 1b trial 64 prospective observational 64 prospective multicenter 64 J Clin Oncol 63 substudy 63 phase IIa 63 HER2 positive metastatic breast 63 axitinib 63 multicenter clinical 63 registrational trial 63 decitabine 63 subgroup analyzes 63 Multicenter 63 multicenter 63 PRECiSE 63 multicenter randomized 62 elotuzumab 62 Pharmacokinetic 62 phase IIb 62 Amrubicin 62 Cooperative Oncology 62 liver transplant recipients 62 mRCC 61 Phase 2a trial 61 prospective randomized controlled 61 Phase IIa trial 61 placebo controlled clinical trials 61 Cancer Res 61 plus prednisone 61 adecatumumab 61 talabostat 61 #:#-# [031] 61 aflibercept 61 randomized controlled clinical 60 vitro experiments 60 Carfilzomib 60 Phase 1b clinical 60 double blinded placebo 60 Phase Ib 60 multicentre 60 multicenter study 60 MORAb 60 Arch Intern Med 60 Apixaban 60 TRITON TIMI 60 metastatic hormone refractory 60 multicenter randomized double 60 HSCT 60 irbesartan 60 placebo controlled randomized 60 nab paclitaxel 60 Arch Neurol 60 Phase Ia 60 XELOX 60 blind randomized controlled 59 tesmilifene 59 Imprime PGG 59 CR# vcMMAE 59 retrospective cohort study 59 ECOG 59 Glioma 59 randomized controlled clinical trials 59 dose escalation trial 59 Ann Intern Med 59 xenograft models 59 ZD# [001] 59 active comparator 59 Metastatic Melanoma 59 Pivotal Phase III 59 Phase 2b trial 59 AASLD 59 Cloretazine R VNP#M 59 neoadjuvant chemotherapy 59 relapsed refractory multiple myeloma 59 immunohistochemical 59 Taxotere ® 59 Phase 2a clinical 58 multivariate analyzes 58 randomized trials 58 sunitinib 58 Cethromycin 58 GRN#L 58 Irinotecan 58 BAY #-# 58 ClinicalTrials.gov 58 azacitidine 58 PARP inhibitor

Back to home page